WearOptimo Introduces World-Class Advisory Board to Further Advance Microwearable Sensor Technology for Precision Health Monitoring [Yahoo! Finance]
Alnylam Pharmaceuticals, Inc. (ALNY)
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.alnylam.com/investor-overview
Company Research
Source: Yahoo! Finance
BRISBANE, Australia and NEW YORK March 11, 2025 /PRNewswire/ -- WearOptimo , a healthcare technology company developing next-generation Microwearable sensors for hydration and biomarker monitoring, today introduced its Advisory Board comprised of globally recognized experts in biotechnology, healthcare, regulatory affairs, and venture investment. WearOptimo Logo The formation of the six-member board is part of the company's plan to accelerate the development of its Microwearable hydration sensor and U.S. launch timeline with a first focus on the professional and elite amateur sports market. WearOptimo's first application of its technology, the hydration sensor, is the only wearable that enables genuine real-time
Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALNY alerts
High impacting Alnylam Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ALNY
News
- Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target raised by analysts at JPMorgan Chase & Co. from $272.00 to $280.00. They now have a "neutral" rating on the stock.MarketBeat
- Alnylam to Webcast Presentation at Stifel 2025 Virtual CNS ForumBusiness Wire
- Dr. Phillip A. Sharp Retirement From Alnylam Pharmaceuticals (NasdaqGS:ALNY) Board Announced [Yahoo! Finance]Yahoo! Finance
- Alnylam Announces Retirement of Longtime Board Member, Dr. Phillip A. Sharp, Company Co-Founder and Industry Luminary [Yahoo! Finance]Yahoo! Finance
- Alnylam Announces Retirement of Longtime Board Member, Dr. Phillip A. Sharp, Company Co-Founder and Industry LuminaryBusiness Wire
ALNY
Earnings
- 2/13/25 - Beat
ALNY
Sec Filings
- 3/5/25 - Form 8-K
- 3/5/25 - Form 4
- 3/5/25 - Form 4
- ALNY's page on the SEC website